Skip to main content
. 2017 Jan 30;8(3):606–615. doi: 10.1039/c7md00014f

Table 2. Radical inhibition of the selenosulfonation of cyclopropylacetylene by carvedilol (1), its metabolites 4–6 and benchmark compounds 9–11.

Compound t 1/2 (min) Time to completion (min)
No inhibitor 4.6 30
BHT (9) 7.9 45
4-Hydroxycarbazole (10) 32.4 90
α-Tocopherol (11) 27.8 60
Carvedilol (1) 4.6 30
4′-Hydroxycarvedilol (4) 8.7 45
5′-Hydroxycarvedilol (5) 13.8 90
3-Hydroxycarvedilol (6) 64.6 180